围术期补充氧气对心脏风险患者术后脑钠肽浓度的影响:一项前瞻性随机临床试验方案
本研究为单中心、双盲、随机对照试验方案,计划纳入260例具有心血管危险因素并接受中高危非心脏手术的患者,比较术中及术后2小时吸入80%与30%氧浓度对术后NT-proBNP最大释放量的影响,并评估肌钙蛋白T、氧化还原电位、血管性血友病因子及围术期液体需求等次要结局。
要点
- 术后NT-proBNP升高可预测非心脏手术心脏不良事件。
- 试验比较80%与30%围术期氧浓度对NT-proBNP释放的影响。
- 纳入260例中高危非心脏手术且伴心血管危险因素患者。
核心结论
- 该试验旨在确定围术期补充氧气能否减少术前心血管风险升高的非心脏手术患者术后NT-proBNP释放。
研究设计与样本
- 单中心、双盲、随机临床试验方案,在维也纳医科大学开展,计划纳入260例具有心血管危险因素并接受中高危非心脏手术的患者。
- 患者随机接受术中及术后2小时80%或30%氧气吸入。
主要发现
- 主要结局为术后NT-proBNP最大释放量的差异。
- 次要结局包括术后肌钙蛋白T最大浓度、氧化还原电位、血管性血友病因子浓度及围术期液体需求。
- 结局测量在术后2小时、术后第1天及第3天进行,NT-proBNP和氧化还原电位还在出院前72小时内测量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Elevated postoperative N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations are predictive for cardiac adverse events in noncardiac surgery. Studies indicate that supplemental oxygen decreases sympathetic nerve activity and might, therefore, improve cardiovascular function. Thus, we will test the effect of perioperative supplemental oxygen administration on NT-proBNP release after surgery. METHODS/DESIGN: We will conduct a single-center, double-blinded, randomized trial at the Medical University of Vienna, including 260 patients with increased cardiac risk factors undergoing moderate- to high-risk noncardiac surgery. Patients will be randomly assigned to receive 80% versus 30% oxygen during surgery and for 2 h postoperatively. The primary outcome will be the difference in maximum NT-proBNP release after surgery. As secondary outcomes we will assess the effect of supplemental oxygen on postoperative maximum troponin T concentration, oxidation-reduction potential, von Willebrand factor concentration and perioperative fluid requirements. We will perform outcome measurements 2 h after surgery, on postoperative day 1 and on postoperative day 3. The NT-proBNP concentration and the oxidation-reduction potential will also be measured within 72 h before discharge. DISCUSSION: Our trial should determine whether perioperative supplemental oxygen administration will reduce the postoperative release of NT-proBNP in patients with preoperative increased cardiovascular risk factors undergoing noncardiac surgery. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT03366857. Registered on 8th December 2017.
引用
- Reiterer C, Kabon B, von Sonnenburg MF, et al. The effect of supplemental oxygen on perioperative brain natriuretic peptide concentration in cardiac risk patients - a protocol for a prosprective randomized clinical trial. Trials. 2020. PMID: 32398119. doi:10.1186/s13063-020-04336-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。